Moreover, NR3C1 expression correlated with disease‐free survival (DFS) in patients with GC, with a hazard ratio (HR) of 1.8 (p = 0.0032) in Gene Expression Profiling Interactive Analysis (GEPIA) (http://gepia.cancer‐pku.cn/),[28] indicating that patients with high NR3C1 expression had shorter DFS and worse prognosis (Figure 2K). The gene discussed is NR3C1; the disease is gastric cancer.